{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:19Z","timestamp":1793900539110,"version":"4.8.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key R&D Program of China","award":["2018YFA0107500, 2017YFA0504503"],"award-info":[{"award-number":["2018YFA0107500, 2017YFA0504503"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["2019J01298"],"award-info":[{"award-number":["2019J01298"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630070, 81772940, 81972599, 81972254, 81802737"],"award-info":[{"award-number":["81630070, 81772940, 81972599, 81972254, 81802737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver cancer is one of the most common malignancies in the world with a poor prognosis. Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, accounting for 80\u201390% of cases. The initiation and progression of HCC are closely associated with chronic liver inflammation. In addition, HCC is often accompanied by cell senescence. Senescent hepatocytes can secrete various inflammatory factors, collectively called the senescence-associated secretory phenotype (SASP). The SASP has been confirmed to promote the occurrence of liver cancer by affecting the inflammatory microenvironment. However, its role and the underlying mechanism of hepatic SASP in hepatocarcinogenesis are not clearly understood. Therefore, a better understanding of the pathogenic mechanisms of the effect of the hepatic SASP on the occurrence of HCC is still needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study aims to explore the role of SASP factors and the underlying mechanism in tumorigenesis and the progression of HCC in vivo. We used diethylnitrosamine (DEN) combined with carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) (DEN-CCl\n                      <jats:sub>4<\/jats:sub>\n                      ) to establish liver cancer model in wild-type (\n                      <jats:italic>WT<\/jats:italic>\n                      ) mice and Bcl3 knockout (\n                      <jats:italic>Bcl3<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      ) mice. \u03b2-galactosidase (\u03b2-gal) staining was performed to evaluate the degree of cellular senescence. Immunohistochemistry (IHC) were used to detect the degree of cellular senescence and the activation of macrophage. PCR chip and clinical tissue chip assays were used to estimate the RNA levels of SASP factors and NF-\u03baB related genes, and their protein levels were examined by Western blot assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      DEN-CCl\n                      <jats:sub>4<\/jats:sub>\n                      induced cellular senescence in mouse hepatocytes. In addition, senescent hepatocytes might release a variety of inflammatory factors that further activate macrophages, thereby changing the microenvironmental state and promoting the occurrence of HCC. Mechanistically, the NF-\u03baB pathway is important because it regulates the SASP. Therefore, we used a PCR chip to detect the expression of NF-\u03baB-related genes in senescent liver tissue. Our results showed that the expression of Bcl3 was increased in senescent hepatocytes, and knocking out Bcl3 significantly inhibited the secretion of hepatocyte SASP factors and the activation of macrophages, thereby inhibiting hepatocarcinogenesis. Finally, in clinical tissues adjacent to HCC tissues in patients, the expression of Bcl3 and IL-8 correlated with poor prognosis in HCC patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The hepatic SASP can further induce the activation of macrophages during hepatocarcinogenesis, thereby promoting the occurrence of HCC, and that this process is closely related to the expression of Bcl3 in hepatocytes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-021-00683-5","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T08:03:04Z","timestamp":1631779384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages"],"prefix":"10.1186","volume":"11","author":[{"given":"Yihua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0575-8676","authenticated-orcid":false,"given":"Aimin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"10","key":"683_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"683_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2020","unstructured":"Sung H, Ferlay J, Siegel R, et al. Global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"683_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020;72(2):250\u201361.","journal-title":"J Hepatol"},{"issue":"1","key":"683_CR4","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","volume":"10","author":"L Wei","year":"2019","unstructured":"Wei L, Lee D, Law CT, et al. Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nat Commun. 2019;10(1):4681.","journal-title":"Nat Commun"},{"issue":"1","key":"683_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"F Greten","year":"2019","unstructured":"Greten F, Grivennikov S. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"34","key":"683_CR6","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.3748\/wjg.v25.i34.5069","volume":"25","author":"N Huda","year":"2019","unstructured":"Huda N, Liu G, Hong H, et al. Hepatic senescence, the good and the bad. World J Gastroenterol. 2019;25(34):5069\u201381.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"683_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, et al. Cellular senescence: defining a path forward. Cell. 2019;179(4):813\u201327.","journal-title":"Cell"},{"issue":"47","key":"683_CR8","doi-asserted-by":"publisher","first-page":"17851","DOI":"10.3748\/wjg.v20.i47.17851","volume":"20","author":"KM Irvine","year":"2014","unstructured":"Irvine KM, Skoien R, Bokil NJ, et al. Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World J Gastroenterol. 2014;20(47):17851\u201362.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"683_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14728222.2019.1565658","volume":"23","author":"L Lau","year":"2019","unstructured":"Lau L, David G. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype. Expert Opin Ther Targets. 2019;23(12):1041\u201351.","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"683_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/ncb2811","volume":"15","author":"M Hoare","year":"2013","unstructured":"Hoare M, Narita M. Transmitting senescence to the cell neighbourhood. Nat Cell Biol. 2013;15(8):887\u20139.","journal-title":"Nat Cell Biol"},{"issue":"7374","key":"683_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang TW, Yevsa T, Woller N, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479(7374):547\u201351.","journal-title":"Nature"},{"issue":"7128","key":"683_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007;445(7128):656\u201360.","journal-title":"Nature"},{"issue":"1","key":"683_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ccell.2018.06.007","volume":"34","author":"A Georgilis","year":"2018","unstructured":"Georgilis A, Klotz S, Hanley C, et al. PTBP1-mediated alternative splicing regulates the inflammatory secretome and the pro-tumorigenic effects of senescent cells. Cancer Cell. 2018;34(1):85-102.e109.","journal-title":"Cancer Cell"},{"issue":"3","key":"683_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","volume":"132","author":"N Wajapeyee","year":"2008","unstructured":"Wajapeyee N, Serra R, Zhu X, et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132(3):363\u201374.","journal-title":"Cell"},{"issue":"6","key":"683_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41556-020-0511-2","volume":"22","author":"F Li","year":"2020","unstructured":"Li F, Huangyang P, Burrows M, et al. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol. 2020;22(6):728\u201339.","journal-title":"Nat Cell Biol"},{"key":"683_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, et al. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"683_CR17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ccell.2016.09.003","volume":"30","author":"T Eggert","year":"2016","unstructured":"Eggert T, Wolter K, Ji J, et al. Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell. 2016;30(4):533\u201347.","journal-title":"Cancer Cell"},{"issue":"7","key":"683_CR18","doi-asserted-by":"publisher","first-page":"e1440166","DOI":"10.1080\/2162402X.2018.1440166","volume":"7","author":"P Xiao","year":"2018","unstructured":"Xiao P, Long X, Zhang L, et al. Neurotensin\/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncoimmunology. 2018;7(7):e1440166.","journal-title":"Oncoimmunology"},{"issue":"1","key":"683_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso A, Revandkar A, Di Mitri D, et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 2014;9(1):75\u201389.","journal-title":"Cell Rep"},{"key":"683_CR20","doi-asserted-by":"publisher","first-page":"11762","DOI":"10.1038\/ncomms11762","volume":"7","author":"MK Ruhland","year":"2016","unstructured":"Ruhland MK, Loza AJ, Capietto AH, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. 2016;7:11762.","journal-title":"Nat Commun"},{"issue":"4","key":"683_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cellsig.2011.12.006","volume":"24","author":"A Salminen","year":"2012","unstructured":"Salminen A, Kauppinen A, Kaarniranta K. Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal. 2012;24(4):835\u201345.","journal-title":"Cell Signal"},{"key":"683_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","volume":"117","author":"S Lopes-Paciencia","year":"2019","unstructured":"Lopes-Paciencia S, Saint-Germain E, Rowell MC, et al. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15\u201322.","journal-title":"Cytokine"},{"issue":"1","key":"683_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville M, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci. 2005;30(1):43\u201352.","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"683_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(93)90401-B","volume":"72","author":"V Bours","year":"1993","unstructured":"Bours V, Franzoso G, Azarenko V, et al. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell. 1993;72(5):729\u201339.","journal-title":"Cell"},{"issue":"1","key":"683_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/j.1460-2075.1993.tb05647.x","volume":"12","author":"M Naumann","year":"1993","unstructured":"Naumann M, Wulczyn F, Scheidereit C. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B. EMBO J. 1993;12(1):213\u201322.","journal-title":"EMBO J"},{"issue":"6","key":"683_CR26","first-page":"3557","volume":"13","author":"G Nolan","year":"1993","unstructured":"Nolan G, Fujita T, Bhatia K, et al. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol Cell Biol. 1993;13(6):3557\u201366.","journal-title":"Mol Cell Biol"},{"issue":"34","key":"683_CR27","doi-asserted-by":"publisher","first-page":"32080","DOI":"10.1074\/jbc.M102949200","volume":"276","author":"AR Brasier","year":"2001","unstructured":"Brasier AR, Lu M, Hai T, et al. NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50\/NF-kappa B1 residence. J Biol Chem. 2001;276(34):32080\u201393.","journal-title":"J Biol Chem"},{"key":"683_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12026-008-8075-4","volume":"42","author":"S Palmer","year":"2008","unstructured":"Palmer S, Chen Y. Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription. Immunol Res. 2008;42:210\u20138.","journal-title":"Immunol Res"},{"issue":"1","key":"683_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1098-2264(199601)15:1<38::AID-GCC6>3.0.CO;2-5","volume":"15","author":"L Michaux","year":"1996","unstructured":"Michaux L, Mecucci C, Stul M, et al. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosom Cancer. 1996;15(1):38\u201347.","journal-title":"Genes Chromosom Cancer"},{"issue":"6","key":"683_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/0092-8674(90)90347-H","volume":"60","author":"H Ohno","year":"1990","unstructured":"Ohno H, Takimoto G, McKeithan T. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell. 1990;60(6):991\u20137.","journal-title":"Cell"},{"issue":"10","key":"683_CR31","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/art.39266","volume":"67","author":"K Meguro","year":"2015","unstructured":"Meguro K, Suzuki K, Hosokawa J, et al. Role of Bcl-3 in the development of follicular helper T cells and in the pathogenesis of rheumatoid arthritis. Arthrit Rheumatol. 2015;67(10):2651\u201360.","journal-title":"Arthrit Rheumatol"},{"issue":"2","key":"683_CR32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/cei.12119","volume":"173","author":"C O'Carroll","year":"2013","unstructured":"O\u2019Carroll C, Moloney G, Hurley G, et al. Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse. Clin Exp Immunol. 2013;173(2):332\u201342.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"683_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1172\/JCI42596","volume":"121","author":"D Kreisel","year":"2011","unstructured":"Kreisel D, Sugimoto S, Tietjens J, et al. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J Clin Invest. 2011;121(1):265\u201376.","journal-title":"J Clin Invest"},{"issue":"2","key":"683_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.gastro.2015.10.017","volume":"150","author":"L Song","year":"2016","unstructured":"Song L, Wormann S, Ai J, et al. BCL3 reduces the sterile inflammatory response in pancreatic and biliary tissues. Gastroenterology. 2016;150(2):499-512 e420.","journal-title":"Gastroenterology"},{"key":"683_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-10-152","volume":"10","author":"V Maldonado","year":"2011","unstructured":"Maldonado V, Melendez-Zajgla J. Role of Bcl-3 in solid tumors. Mol Cancer. 2011;10:152.","journal-title":"Mol Cancer"},{"issue":"13","key":"683_CR36","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1182\/blood-2004-09-3620","volume":"106","author":"S Mathas","year":"2005","unstructured":"Mathas S, Johrens K, Joos S, et al. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood. 2005;106(13):4287\u201393.","journal-title":"Blood"},{"issue":"12","key":"683_CR37","doi-asserted-by":"publisher","first-page":"e2508","DOI":"10.1038\/cddis.2016.405","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen X, Cao X, Sun X, et al. Bcl-3 regulates TGF\u03b2 signaling by stabilizing Smad3 during breast cancer pulmonary metastasis. Cell Death Dis. 2016;7(12):e2508.","journal-title":"Cell Death Dis"},{"issue":"4","key":"683_CR38","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3892\/or.2016.4616","volume":"35","author":"K Tu","year":"2016","unstructured":"Tu K, Liu Z, Yao B, et al. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1. Oncol Rep. 2016;35(4):2382\u201390.","journal-title":"Oncol Rep"},{"issue":"12","key":"683_CR39","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.4049\/jimmunol.1300611","volume":"191","author":"X Zhang","year":"2013","unstructured":"Zhang X, Paun A, Claudio E, et al. The tumor promoter and NF-kappaB modulator Bcl-3 regulates splenic B cell development. J Immunol. 2013;191(12):5984\u201392.","journal-title":"J Immunol"},{"issue":"4","key":"683_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"D Dapito","year":"2012","unstructured":"Dapito D, Mencin A, Gwak G, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504\u201316.","journal-title":"Cancer Cell"},{"issue":"1","key":"683_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","volume":"63","author":"P Kocabayoglu","year":"2015","unstructured":"Kocabayoglu P, Lade A, Lee YA, et al. beta-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J Hepatol. 2015;63(1):141\u20137.","journal-title":"J Hepatol"},{"issue":"1","key":"683_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41418-019-0340-7","volume":"27","author":"WT Liu","year":"2020","unstructured":"Liu WT, Jing YY, Gao L, et al. Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts constitutes the hepatocarcinogenesis-associated microenvironment. Cell Death Differ. 2020;27(1):85\u2013101.","journal-title":"Cell Death Differ"},{"issue":"5","key":"683_CR43","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3892\/or.2015.4268","volume":"34","author":"F Zhu","year":"2015","unstructured":"Zhu F, Li X, Jiang Y, et al. GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumorassociated macrophages. Oncol Rep. 2015;34(5):2643\u201355.","journal-title":"Oncol Rep"},{"issue":"4","key":"683_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky V, Yon M, Dickins RA, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008;134(4):657\u201367.","journal-title":"Cell"},{"issue":"7456","key":"683_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97\u2013101.","journal-title":"Nature"},{"issue":"1","key":"683_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mc.23270","volume":"60","author":"N Alraouji","year":"2021","unstructured":"Alraouji N, Aboussekhra A. Tocilizumab inhibits IL-8 and the proangiogenic potential of triple negative breast cancer cells. Mol Carcinog. 2021;60(1):51\u20139.","journal-title":"Mol Carcinog"},{"issue":"5","key":"683_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41591-020-0873-9","volume":"26","author":"Z Bakouny","year":"2020","unstructured":"Bakouny Z, Choueiri TK. IL-8 and cancer prognosis on immunotherapy. Nat Med. 2020;26(5):650\u20131.","journal-title":"Nat Med"},{"issue":"1","key":"683_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2006.10.028","volume":"251","author":"Y Tachibana","year":"2007","unstructured":"Tachibana Y, Nakamoto Y, Mukaida N, et al. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C. Cancer Lett. 2007;251(1):36\u201342.","journal-title":"Cancer Lett"},{"issue":"6","key":"683_CR49","doi-asserted-by":"publisher","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","volume":"6","author":"HW Zimmermann","year":"2011","unstructured":"Zimmermann HW, Seidler S, Gassler N, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE. 2011;6(6):e21381.","journal-title":"PLoS ONE"},{"issue":"4","key":"683_CR50","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/hep.20650","volume":"41","author":"AD Clouston","year":"2005","unstructured":"Clouston AD, Powell EE, Walsh MJ, et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology. 2005;41(4):809\u201318.","journal-title":"Hepatology"},{"issue":"4","key":"683_CR51","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.26937","volume":"59","author":"VL Gadd","year":"2014","unstructured":"Gadd VL, Skoien R, Powell EE, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59(4):1393\u2013405.","journal-title":"Hepatology"},{"issue":"3","key":"683_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/hupa.2001.22747","volume":"32","author":"V Paradis","year":"2001","unstructured":"Paradis V, Youssef N, Dargere D, et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol. 2001;32(3):327\u201332.","journal-title":"Hum Pathol"},{"issue":"6","key":"683_CR53","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC, O\u2019Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008;133(6):1006\u201318.","journal-title":"Cell"},{"issue":"3","key":"683_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0030-1255351","volume":"30","author":"HE Wasmuth","year":"2010","unstructured":"Wasmuth HE, Tacke F, Trautwein C. Chemokines in liver inflammation and fibrosis. Semin Liver Dis. 2010;30(3):215\u201325.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"683_CR55","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1158\/0008-5472.CAN-12-1321","volume":"73","author":"A Wakefield","year":"2013","unstructured":"Wakefield A, Soukupova J, Montagne A, et al. Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors. Cancer Res. 2013;73(2):745\u201355.","journal-title":"Cancer Res"},{"issue":"3","key":"683_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbrc.2010.08.084","volume":"400","author":"HJ Choi","year":"2010","unstructured":"Choi HJ, Lee JM, Kim H, et al. Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer. Biochem Biophys Res Commun. 2010;400(3):396\u2013402.","journal-title":"Biochem Biophys Res Commun"},{"issue":"44","key":"683_CR57","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1038\/s41388-018-0363-4","volume":"37","author":"Y Tao","year":"2018","unstructured":"Tao Y, Liu Z, Hou Y, et al. Alternative NF-\u03baB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3. Oncogene. 2018;37(44):5887\u2013900.","journal-title":"Oncogene"},{"issue":"7","key":"683_CR58","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1038\/emm.2017.89","volume":"49","author":"J Poveda","year":"2017","unstructured":"Poveda J, Sanz AB, Carrasco S, et al. Bcl3: a regulator of NF-\u03baB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells. Exp Mol Med. 2017;49(7):e352\u2013e352.","journal-title":"Exp Mol Med"},{"issue":"11","key":"683_CR59","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.bbamcr.2014.07.012","volume":"1843","author":"TP Chang","year":"2014","unstructured":"Chang TP, Vancurova I. Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma. Biochim Biophys Acta. 2014;1843(11):2620\u201330.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"683_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549\u201355.","journal-title":"Trends Immunol"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T09:05:29Z","timestamp":1631783129000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00683-5","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"29 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimentation and breeding of all mouse lines were approved by the Second Military Medical University Animal Care Committee. Prior informed consent was obtained, and all patient samples were approved by the Ethics Committee of the Shanghai Eastern Hepatobiliary Surgery Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reached an agreement to publish the study in this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}